Financials
- Market Capitalization 6 B
- Employee 370
- Founded 1996
- CEO N/A
- Website www.xenon-pharma.com
- Headquarter British Columbia, Canada
- FIGI BBG0073DM784
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-12.73
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1202 | DNTH Dianthus Therapeutics, Inc. - Common Stock | 111.54 USD | +0.70% | +1.00% | +9.22% | +350.85% | 6.24 B USD | ||
| 1209 | BLTE Belite Bio Inc - American Depositary Shares | 157.01 USD | +0.20% | -3.97% | +2.48% | +146.10% | 6.18 B USD | ||
| 1229 | PTCT PTC Therapeutics, Inc. - Common Stock | 71.81 USD | -1.21% | +1.80% | -4.06% | +44.14% | 5.99 B USD | ||
| 1245 | DFTX Definium Therapeutics, Inc. - Common Shares | 43.82 USD | +0.11% | -4.51% | +4.33% | +190.01% | 5.89 B USD |